{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:44:05Z","timestamp":1790685845086,"version":"4.1.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s13555-020-00465-w","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T18:34:18Z","timestamp":1606415658000},"page":"39-52","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["The Microbiome in Hidradenitis Suppurativa: A Review"],"prefix":"10.1007","volume":"11","author":[{"given":"Kirsty J. L.","family":"Wark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey D.","family":"Cains","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,26]]},"reference":[{"issue":"2","key":"465_CR1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMcp1014163","volume":"366","author":"GB Jemec","year":"2012","unstructured":"Jemec GB. Hidradenitis suppurativa. NEJM. 2012;366(2):158\u201364.","journal-title":"NEJM"},{"issue":"9","key":"465_CR2","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/apm.12220","volume":"122","author":"AC Jahns","year":"2014","unstructured":"Jahns AC, Killasli H, Nosek D, et al. Microbiology of hidradenitis suppurativa (acne inversa): a histological study of 27 patients. APMIS. 2014;122(9):804\u20139.","journal-title":"APMIS"},{"issue":"1","key":"465_CR3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-020-0149-1","volume":"6","author":"R Sabat","year":"2020","unstructured":"Sabat R, Jemec GBE, Matusiak \u0141, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Prim. 2020;6(1):18.","journal-title":"Nat Rev Dis Prim"},{"issue":"6","key":"465_CR4","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/bjd.14038","volume":"173","author":"D Saunte","year":"2015","unstructured":"Saunte D, Boer J, Stratigos A, et al. Diagnostic delay in hidradenitis suppurativa is a global problem. Br J Dermatol. 2015;173(6):1546\u20139.","journal-title":"Br J Dermatol"},{"issue":"6","key":"465_CR5","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jaad.2014.09.012","volume":"71","author":"J Shlyankevich","year":"2014","unstructured":"Shlyankevich J, Chen AJ, Kim GE, Kimball AB. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis. J Am Acad Dermatol. 2014;71(6):1144\u201350.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"465_CR6","first-page":"e28","volume":"61","author":"K Phan","year":"2020","unstructured":"Phan K, Charlton O, Smith SD. Hidradenitis suppurativa and polycystic ovarian syndrome: systematic review and meta-analysis. Austral J Dermatol. 2020;61(1):e28\u201333.","journal-title":"Austral J Dermatol"},{"issue":"5","key":"465_CR7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2340\/00015555-1800","volume":"94","author":"CB Kromann","year":"2014","unstructured":"Kromann CB, Ibler KS, Kristiansen VB, Jemec GB. The influence of body weight on the prevalence and severity of hidradenitis suppurativa. Acta Derm Venereol. 2014;94(5):553\u20137.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"465_CR8","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","volume":"161","author":"K Sartorius","year":"2009","unstructured":"Sartorius K, Emtestam L, Jemec G, Lapins J. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol. 2009;161(4):831\u20139.","journal-title":"Br J Dermatol"},{"issue":"4","key":"465_CR9","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1111\/ced.13922","volume":"44","author":"K Phan","year":"2019","unstructured":"Phan K, Charlton O, Smith S. Hidradenitis suppurativa and diabetes mellitus: updated systematic review and adjusted meta-analysis. Clin Exp Dermatol. 2019;44(4):e126\u201332.","journal-title":"Clin Exp Dermatol"},{"issue":"12","key":"465_CR10","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jamadermatol.2014.1165","volume":"150","author":"IM Miller","year":"2014","unstructured":"Miller IM, Ellervik C, Vinding GR, et al. Association of metabolic syndrome and hidradenitis suppurativa. JAMA Dermatol. 2014;150(12):1273\u201380.","journal-title":"JAMA Dermatol"},{"key":"465_CR11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/CCID.S111019","volume":"10","author":"M Napolitano","year":"2017","unstructured":"Napolitano M, Megna M, Timoshchuk EA, et al. Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment. Clin Cosmet Investig Dermatol. 2017;10:105.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"2","key":"465_CR12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000462979","volume":"3","author":"N Scuderi","year":"2017","unstructured":"Scuderi N, Monfrecola A, Dessy LA, Fabbrocini G, Megna M, Monfrecola G. Medical and surgical treatment of hidradenitis suppurativa: a review. Skin Append Disord. 2017;3(2):95\u2013110.","journal-title":"Skin Append Disord"},{"issue":"1","key":"465_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00005-018-0528-4","volume":"67","author":"A Balato","year":"2019","unstructured":"Balato A, Cacciapuoti S, Di Caprio R, et al. Human microbiome: composition and role in inflammatory skin diseases. Arch Immunol Ther Exp. 2019;67(1):1\u201318.","journal-title":"Arch Immunol Ther Exp"},{"issue":"1","key":"465_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms2441","volume":"4","author":"T Nakatsuji","year":"2013","unstructured":"Nakatsuji T, Chiang H-I, Jiang SB, Nagarajan H, Zengler K, Gallo RL. The microbiome extends to subepidermal compartments of normal skin. Nat Commun. 2013;4(1):1\u20138.","journal-title":"Nat Commun"},{"issue":"3","key":"465_CR15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/jdv.15951","volume":"34","author":"B Polkowska-Pruszy\u0144ska","year":"2020","unstructured":"Polkowska-Pruszy\u0144ska B, Gerkowicz A, Krasowska D. The gut microbiome alterations in allergic and inflammatory skin diseases\u2014an update. J Eur Acad Dermatol Venereol. 2020;34(3):455\u201364.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"465_CR16","first-page":"1","volume":"10","author":"SL Prescott","year":"2017","unstructured":"Prescott SL, Larcombe D-L, Logan AC, et al. The skin microbiome: impact of modern environments on skin ecology, barrier integrity, and systemic immune programming. World Allergy Org J. 2017;10(1):1\u201316.","journal-title":"World Allergy Org J"},{"issue":"4","key":"465_CR17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nri.2017.7","volume":"17","author":"M Levy","year":"2017","unstructured":"Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219\u201332.","journal-title":"Nat Rev Immunol"},{"issue":"24","key":"465_CR18","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","volume":"375","author":"SV Lynch","year":"2016","unstructured":"Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. 2016;375(24):2369\u201379.","journal-title":"N Engl J Med"},{"key":"465_CR19","unstructured":"Macklis P, Adams K, Kaffenberger J, Kumar P, Krispinsky A, Kaffenberger B. The association between oral health and skin disease. J Clin Aesthet Dermatol. 2020;13(6):48\u201353."},{"key":"465_CR20","doi-asserted-by":"crossref","unstructured":"Vekic DA, Cains GD. Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 2. Austral J Dermatol. 2018;59(4):261\u20136.","DOI":"10.1111\/ajd.12766"},{"key":"465_CR21","doi-asserted-by":"crossref","unstructured":"Riverain-Gillet \u00c9, Guet-Revillet H, Jais J-P, et al. The surface microbiome of clinically unaffected skinfolds in hidradenitis suppurativa: a cross-sectional culture based and 16S rRNA gene amplicon sequencing study in 60 patients. J Investig Dermatol. 2020;140(9):1847\u201355.e6.","DOI":"10.1016\/j.jid.2020.02.046"},{"key":"465_CR22","doi-asserted-by":"crossref","unstructured":"Naik HB, Jo J-H, Paul M, Kong HH. Skin microbiota perturbations are distinct and disease severity-dependent in hidradenitis suppurativa. J Investig Dermatol. 2019;140(4):922\u20135.e3.","DOI":"10.1016\/j.jid.2019.08.445"},{"issue":"9","key":"465_CR23","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/jdv.15597","volume":"33","author":"H Ring","year":"2019","unstructured":"Ring H, Sigsgaard V, Thorsen J, et al. The microbiome of tunnels in hidradenitis suppurativa patients. J Eur Acad Dermatol Venereol. 2019;33(9):1775\u201380.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"465_CR24","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/cid\/cix285","volume":"65","author":"H Guet-Revillet","year":"2017","unstructured":"Guet-Revillet H, Jais J-P, Ungeheuer M-N, et al. The microbiological landscape of anaerobic infections in hidradenitis suppurativa: a prospective metagenomic study. Clin Infect Dis. 2017;65(2):282\u201391.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"465_CR25","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jamadermatol.2017.0904","volume":"153","author":"HC Ring","year":"2017","unstructured":"Ring HC, Thorsen J, Saunte DM, et al. The follicular skin microbiome in patients with hidradenitis suppurativa and healthy controls. JAMA Dermatol. 2017;153(9):897\u2013905.","journal-title":"JAMA Dermatol"},{"issue":"12","key":"465_CR26","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.3201\/eid2012.140064","volume":"20","author":"H Guet-Revillet","year":"2014","unstructured":"Guet-Revillet H, Coignard-Biehler H, Jais J-P, et al. Bacterial pathogens associated with hidradenitis suppurativa, France. Emerg Infect Dis. 2014;20(12):1990.","journal-title":"Emerg Infect Dis"},{"key":"465_CR27","doi-asserted-by":"crossref","unstructured":"Benzecry V, Grancini A, Guanziroli E, et al. Hidradenitis suppurativa\/acne inversa: a prospective bacteriological study of 46 patients and review of the literature. G Ital Dermatol Venereol. 2020;155(4):459\u201363.","DOI":"10.23736\/S0392-0488.18.05875-3"},{"issue":"5","key":"465_CR28","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/jdv.15332","volume":"33","author":"V Bettoli","year":"2019","unstructured":"Bettoli V, Manfredini M, Massoli L, et al. Rates of antibiotic resistance\/sensitivity in bacterial cultures of hidradenitis suppurativa patients. J Eur Acad Dermatol Venereol. 2019;33(5):930\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"465_CR29","first-page":"25","volume":"22","author":"M Jamalpour","year":"2019","unstructured":"Jamalpour M, Saki N, Nozari F. Microbial profile and antibiotic susceptibility of bacteria isolated from patients with hidradenitis suppurativa. Iran J Dermatol. 2019;22(1):25\u20139.","journal-title":"Iran J Dermatol"},{"issue":"4","key":"465_CR30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2340\/00015555-2591","volume":"97","author":"G Nikolakis","year":"2017","unstructured":"Nikolakis G, Liakou AI, Bonovas S, et al. Bacterial colonization in hidradenitis suppurativa\/acne inversa: a cross-sectional study of 50 patients and review of the literature. Acta Derm Venereol. 2017;97(4):493\u20138.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"465_CR31","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/000313481608200423","volume":"82","author":"C Thomas","year":"2016","unstructured":"Thomas C, Rodby KA, Thomas J, Shay E, Antony AK. Recalcitrant hidradenitis suppurativa: an investigation of demographics, surgical management, bacterial isolates, pharmacologic intervention, and patient-reported health outcomes. Am Surg. 2016;82(4):362\u20138.","journal-title":"Am Surg"},{"issue":"3","key":"465_CR32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000446812","volume":"29","author":"S Hessam","year":"2016","unstructured":"Hessam S, Sand M, Georgas D, Anders A, Bechara FG. Microbial profile and antimicrobial susceptibility of bacteria found in inflammatory hidradenitis suppurativa lesions. Skin Pharmacol Physiol. 2016;29(3):161\u20137.","journal-title":"Skin Pharmacol Physiol"},{"issue":"2","key":"465_CR33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000381959","volume":"1","author":"AC Katoulis","year":"2015","unstructured":"Katoulis AC, Koumaki D, Liakou AI, et al. Aerobic and anaerobic bacteriology of hidradenitis suppurativa: a study of 22 cases. Skin Append Disord. 2015;1(2):55\u20139.","journal-title":"Skin Append Disord"},{"issue":"6","key":"465_CR34","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2340\/00015555-1841","volume":"94","author":"U Matusiak","year":"2014","unstructured":"Matusiak U, Bieniek A, Szepietowski JC. Bacteriology of hidradenitis suppurativa\u2013which antibiotics are the treatment of choice? Acta Derm Venereol. 2014;94(6):699\u2013702.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"465_CR35","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1365-2133.2011.10747.x","volume":"166","author":"K Sartorius","year":"2012","unstructured":"Sartorius K, Killasli H, Oprica C, Sullivan A, Lapins J. Bacteriology of hidradenitis suppurativa exacerbations and deep tissue cultures obtained during carbon dioxide laser treatment. Br J Dermatol. 2012;166(4):879\u201383.","journal-title":"Br J Dermatol"},{"issue":"1","key":"465_CR36","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1365-2133.1999.02613.x","volume":"140","author":"J Lapins","year":"1999","unstructured":"Lapins J, Jarstrand C, Emtestam L. Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery. Br J Dermatol. 1999;140(1):90.","journal-title":"Br J Dermatol"},{"issue":"1","key":"465_CR37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1099\/00222615-48-1-103","volume":"48","author":"I Brook","year":"1999","unstructured":"Brook I, Frazier EH. Aerobic and anaerobic microbiology of axillary hidradenitis suppurativa. J Med Microbiol. 1999;48(1):103\u20135.","journal-title":"J Med Microbiol"},{"issue":"3","key":"465_CR38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000246246","volume":"193","author":"G Jemec","year":"1996","unstructured":"Jemec G, Faber M, Gutschik E, Wendelboe P. The bacteriology of hidradenitis suppurativa. Dermatology. 1996;193(3):203\u20136.","journal-title":"Dermatology"},{"issue":"7","key":"465_CR39","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/archderm.1988.01670070035015","volume":"124","author":"AS Highet","year":"1988","unstructured":"Highet AS, Warren RE, Weekes AJ. Bacteriology and antibiotic treatment of perineal suppurative hidradenitis. Arch Dermatol. 1988;124(7):1047\u201351.","journal-title":"Arch Dermatol"},{"key":"465_CR40","doi-asserted-by":"publisher","unstructured":"Kam S, Collard M, Lam J, Alani RM. Gut microbiome perturbations in patients with hidradenitis suppurativa: a case series. J Investig Dermatol. 2020. https:\/\/doi.org\/10.1016\/j.jid.2020.04.017.","DOI":"10.1016\/j.jid.2020.04.017"},{"issue":"9","key":"465_CR41","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/ecco-jcc\/jjw070","volume":"10","author":"H Eppinga","year":"2016","unstructured":"Eppinga H, Sperna Weiland CJ, Thio HB, et al. Similar depletion of protective Faecalibacterium prausnitzii in psoriasis and inflammatory bowel disease, but not in hidradenitis suppurativa. J Crohns Colitis. 2016;10(9):1067\u201375.","journal-title":"J Crohns Colitis"},{"issue":"1","key":"465_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0924-8579(99)00164-8","volume":"15","author":"ME Falagas","year":"2000","unstructured":"Falagas ME, Siakavellas E. Bacteroides, Prevotella, and Porphyromonas species: a review of antibiotic resistance and therapeutic options. Int J Antimicrob Agents. 2000;15(1):1\u20139.","journal-title":"Int J Antimicrob Agents"},{"key":"465_CR43","doi-asserted-by":"publisher","unstructured":"Lousada M, Lachnit T, Edelkamp J, et al. Exploring the human hair follicle microbiome. Br J Dermatol. 2020. https:\/\/doi.org\/10.1111\/bjd.19461.","DOI":"10.1111\/bjd.19461"},{"key":"465_CR44","doi-asserted-by":"crossref","unstructured":"Mysak J, Podzimek S, Sommerova P, et al. Porphyromonas gingivalis: major periodontopathic pathogen overview. J Immunol Res. 2014;2014.","DOI":"10.1155\/2014\/476068"},{"issue":"4","key":"465_CR45","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/imm.12760","volume":"151","author":"JM Larsen","year":"2017","unstructured":"Larsen JM. The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology. 2017;151(4):363\u201374.","journal-title":"Immunology"},{"issue":"6","key":"465_CR46","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jid.2018.11.018","volume":"139","author":"E Witte-H\u00e4ndel","year":"2019","unstructured":"Witte-H\u00e4ndel E, Wolk K, Tsaousi A, et al. The IL-1 pathway is hyperactive in hidradenitis suppurativa and contributes to skin infiltration and destruction. J Investig Dermatol. 2019;139(6):1294\u2013305.","journal-title":"J Investig Dermatol"},{"issue":"4","key":"465_CR47","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaad.2010.07.010","volume":"65","author":"C Schlapbach","year":"2011","unstructured":"Schlapbach C, H\u00e4nni T, Yawalkar N, Hunger RE. Expression of the IL-23\/Th17 pathway in lesions of hidradenitis suppurativa. J Am Acad Dermatol. 2011;65(4):790\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"465_CR48","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/exd.14036","volume":"29","author":"AHR J\u00f8rgensen","year":"2020","unstructured":"J\u00f8rgensen AHR, Thomsen SF, Karmisholt KE, Ring HC. Clinical, microbiological, immunological and imaging characteristics of tunnels and fistulas in hidradenitis suppurativa and Crohn\u2019s disease. Exp Dermatol. 2020;29(2):118\u201323.","journal-title":"Exp Dermatol"},{"key":"465_CR49","doi-asserted-by":"crossref","unstructured":"Dinh KM, Erikstrup LT, Andersen R, et al. Cross-sectional study identifies lower risk of Staphylococcus aureus nasal colonization in Danish blood donors with hidradenitis suppurativa symptoms. Br J Dermatol. 2020;183(2):387\u20139.","DOI":"10.1111\/bjd.18962"},{"issue":"1","key":"465_CR50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000504537","volume":"236","author":"A Katoulis","year":"2020","unstructured":"Katoulis A, Koumaki V, Efthymiou O, et al. Staphylococcus aureus carriage status in patients with hidradenitis suppurativa: an observational cohort study in a tertiary referral hospital in Athens, Greece. Dermatology. 2020;236(1):31\u20136.","journal-title":"Dermatology"},{"issue":"1","key":"465_CR51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1365-2133.2002.04872.x","volume":"147","author":"K Breuer","year":"2002","unstructured":"Breuer K, H\u00e4ussler S, Kapp A, Werfel T. Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol. 2002;147(1):55\u201361.","journal-title":"Br J Dermatol"},{"issue":"37","key":"465_CR52","doi-asserted-by":"crossref","first-page":"15061","DOI":"10.1073\/pnas.1307855110","volume":"110","author":"C Chehoud","year":"2013","unstructured":"Chehoud C, Rafail S, Tyldsley AS, Seykora JT, Lambris JD, Grice EA. Complement modulates the cutaneous microbiome and inflammatory milieu. Proc Natl Acad Sci. 2013;110(37):15061\u20136.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"465_CR53","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/1523-1747.ep12541202","volume":"70","author":"SI Katz","year":"1978","unstructured":"Katz SI, Strober W. The pathogenesis of dermatitis herpetiformis. J Investig Dermatol. 1978;70(2):63\u201375.","journal-title":"J Investig Dermatol"},{"issue":"2","key":"465_CR54","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1111\/ajd.12909","volume":"60","author":"M Maarouf","year":"2019","unstructured":"Maarouf M, Platto JF, Shi VY. The role of nutrition in inflammatory pilosebaceous disorders: implication of the skin-gut axis. Australas J Dermatol. 2019;60(2):e90\u20138.","journal-title":"Australas J Dermatol"},{"issue":"5","key":"465_CR55","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.surg.2013.04.018","volume":"154","author":"C Cannistr\u00e0","year":"2013","unstructured":"Cannistr\u00e0 C, Finocchi V, Trivisonno A, Tambasco D. New perspectives in the treatment of hidradenitis suppurativa: surgery and brewer\u2019s yeast\u2013exclusion diet. Surgery. 2013;154(5):1126\u201330.","journal-title":"Surgery"},{"key":"465_CR56","doi-asserted-by":"crossref","unstructured":"Aboud C, Zamaria N, Cannistr\u00e0 C. Treatment of hidradenitis suppurativa: surgery and yeast (Saccharomyces cerevisiae)\u2013exclusion diet. Results after 6\u00a0years. Surgery. 2020;167(6):1012\u20135.","DOI":"10.1016\/j.surg.2019.12.015"},{"key":"465_CR57","doi-asserted-by":"crossref","unstructured":"Assan F, Gottlieb J, Tubach F, et al. Anti-Saccharomyces cerevisiae IgG and IgA antibodies are associated with systemic inflammation and advanced disease in hidradenitis suppurativa. J Allergy Clin Immunol. 2020;146(2):452\u20135.e5.","DOI":"10.1016\/j.jaci.2020.01.045"},{"issue":"6","key":"465_CR58","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/gut.42.6.788","volume":"42","author":"J Quinton","year":"1998","unstructured":"Quinton J, Sendid B, Reumaux D, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut. 1998;42(6):788\u201391.","journal-title":"Gut"},{"issue":"9","key":"465_CR59","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/jamadermatol.2019.0891","volume":"155","author":"W-T Chen","year":"2019","unstructured":"Chen W-T, Chi C-C. Association of hidradenitis suppurativa with inflammatory bowel disease: a systematic review and meta-analysis. JAMA Dermatol. 2019;155(9):1022\u20137.","journal-title":"JAMA Dermatol"},{"key":"465_CR60","doi-asserted-by":"crossref","unstructured":"Frew JW, Hawkes JE, Krueger JG. A systematic review and critical evaluation of inflammatory cytokine associations in hidradenitis suppurativa. F1000Research. 2018;7:1930.","DOI":"10.12688\/f1000research.17267.1"},{"issue":"1","key":"465_CR61","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jdv.14538","volume":"32","author":"H Ring","year":"2018","unstructured":"Ring H, Thorsen J, Saunte D, et al. Moderate to severe hidradenitis suppurativa patients do not have an altered bacterial composition in peripheral blood compared to healthy controls. J Eur Acad Dermatol Venereol. 2018;32(1):125\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"465_CR62","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jdin.2020.05.005","volume":"1","author":"JW Frew","year":"2020","unstructured":"Frew JW. Hidradenitis suppurativa is an autoinflammatory keratinization disease: a review of the clinical, histologic, and molecular evidence. JAAD Int. 2020;1(1):62\u201372.","journal-title":"JAAD Int"},{"issue":"4","key":"465_CR63","doi-asserted-by":"crossref","first-page":"e0151990","DOI":"10.1371\/journal.pone.0151990","volume":"11","author":"GI Perez Perez","year":"2016","unstructured":"Perez Perez GI, Gao Z, Jourdain R, et al. Body site is a more determinant factor than human population diversity in the healthy skin microbiome. PLoS One. 2016;11(4):e0151990.","journal-title":"PLoS One"},{"issue":"8","key":"465_CR64","doi-asserted-by":"crossref","first-page":"e1001377","DOI":"10.1371\/journal.pbio.1001377","volume":"10","author":"D Gevers","year":"2012","unstructured":"Gevers D, Knight R, Petrosino JF, et al. The Human Microbiome Project: a community resource for the healthy human microbiome. PLoS Biol. 2012;10(8):e1001377.","journal-title":"PLoS Biol"},{"issue":"7164","key":"465_CR65","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nature06244","volume":"449","author":"PJ Turnbaugh","year":"2007","unstructured":"Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature. 2007;449(7164):804\u201310.","journal-title":"Nature"},{"issue":"5","key":"465_CR66","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00203-018-1506-2","volume":"200","author":"Z Savin","year":"2018","unstructured":"Savin Z, Kivity S, Yonath H, Yehuda S. Smoking and the intestinal microbiome. Arch Microbiol. 2018;200(5):677\u201384.","journal-title":"Arch Microbiol"},{"key":"465_CR67","doi-asserted-by":"crossref","unstructured":"Castaner O, Goday A, Park Y-M, et al. The gut microbiome profile in obesity: a systematic review. Int J Endocrinol. 2018;2018:4095789.","DOI":"10.1155\/2018\/4095789"},{"issue":"9","key":"465_CR68","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.jid.2020.03.946","volume":"140","author":"HB Naik","year":"2020","unstructured":"Naik HB, Piguet V. Standardizing hidradenitis suppurativa skin microbiome research: the methods matter. J Investig Dermatol. 2020;140(9):1688\u201390.","journal-title":"J Investig Dermatol"},{"key":"465_CR69","unstructured":"Prast-Nielsen S, Tobin AM, Adamzik K, et al. Investigation of the skin microbiome: swabs vs. biopsies. Br J Dermatol. 2019;181(3):572\u20139."},{"issue":"1","key":"465_CR70","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/jdv.15183","volume":"33","author":"CB Ardon","year":"2019","unstructured":"Ardon CB, Prens E, Fuursted K, et al. Biofilm production and antibiotic susceptibility of Staphylococcus epidermidis strains from hidradenitis suppurativa lesions. J Eur Acad Dermatol Venereol. 2019;33(1):170\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"465_CR71","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev-micro-092611-150157","volume":"66","author":"M Bing","year":"2012","unstructured":"Bing M, Forney L, Ravel J. The vaginal microbiome: rethinking health and diseases. Annu Rev Microbiol. 2012;66:371\u201389.","journal-title":"Annu Rev Microbiol"},{"issue":"5","key":"465_CR72","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.tim.2014.03.001","volume":"22","author":"AW Walker","year":"2014","unstructured":"Walker AW, Duncan SH, Louis P, Flint HJ. Phylogeny, culturing, and metagenomics of the human gut microbiota. Trends Microbiol. 2014;22(5):267\u201374.","journal-title":"Trends Microbiol"},{"issue":"6","key":"465_CR73","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/bjd.18309","volume":"181","author":"JW Frew","year":"2019","unstructured":"Frew JW, Navrazhina K, Byrd A, et al. Defining lesional, perilesional and unaffected skin in hidradenitis suppurativa: proposed recommendations for clinical trials and translational research studies. Br J Dermatol. 2019;181(6):1339\u201341.","journal-title":"Br J Dermatol"},{"issue":"3","key":"465_CR74","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.jid.2016.01.005","volume":"136","author":"J-H Jo","year":"2016","unstructured":"Jo J-H, Kennedy EA, Kong HH. Research techniques made simple: bacterial 16S ribosomal RNA gene sequencing in cutaneous research. J Investig Dermatol. 2016;136(3):e23\u20137.","journal-title":"J Investig Dermatol"},{"issue":"3","key":"465_CR75","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jid.2016.10.033","volume":"137","author":"HH Kong","year":"2017","unstructured":"Kong HH, Andersson B, Clavel T, et al. Performing skin microbiome research: a method to the madness. J Investig Dermatol. 2017;137(3):561\u20138.","journal-title":"J Investig Dermatol"},{"issue":"2","key":"465_CR76","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1574-695X.2012.00946.x","volume":"65","author":"S Kathju","year":"2012","unstructured":"Kathju S, Lasko L-A, Stoodley P. Considering hidradenitis suppurativa as a bacterial biofilm disease. FEMS Immunol Med Microbiol. 2012;65(2):385\u20139.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"4","key":"465_CR77","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/bjd.15007","volume":"176","author":"H Ring","year":"2017","unstructured":"Ring H, Bay L, Nilsson M, et al. Bacterial biofilm in chronic lesions of hidradenitis suppurativa. Br J Dermatol. 2017;176(4):993\u20131000.","journal-title":"Br J Dermatol"},{"issue":"6","key":"465_CR78","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2217\/fmb.10.56","volume":"5","author":"PD Fey","year":"2010","unstructured":"Fey PD, Olson ME. Current concepts in biofilm formation of Staphylococcus epidermidis. Future Microbiol. 2010;5(6):917\u201333.","journal-title":"Future Microbiol"},{"issue":"12","key":"465_CR79","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","volume":"157","author":"AB Kimball","year":"2012","unstructured":"Kimball AB, Kerdel F, Adams D, et al. Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial. Ann Intern Med. 2012;157(12):846\u201355.","journal-title":"Ann Intern Med"},{"issue":"10","key":"465_CR80","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.3390\/jcm8101646","volume":"8","author":"DG Ribaldone","year":"2019","unstructured":"Ribaldone DG, Caviglia GP, Abdulle A, et al. Adalimumab therapy improves intestinal dysbiosis in Crohn\u2019s disease. J Clin Med. 2019;8(10):1646.","journal-title":"J Clin Med"},{"issue":"10","key":"465_CR81","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/ecco-jcc\/jjv119","volume":"9","author":"D Busquets","year":"2015","unstructured":"Busquets D, Mas-de-Xaxars T, L\u00f3pez-Siles M, et al. Anti-tumour necrosis factor treatment with adalimumab induces changes in the microbiota of Crohn\u2019s disease. J Crohns Colitis. 2015;9(10):899\u2013906.","journal-title":"J Crohns Colitis"},{"issue":"6","key":"465_CR82","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/bjd.17989","volume":"181","author":"E Langan","year":"2019","unstructured":"Langan E, K\u00fcnstner A, Miodovnik M, et al. Combined culture and metagenomic analyses reveal significant shifts in the composition of the cutaneous microbiome in psoriasis. Br J Dermatol. 2019;181(6):1254\u201364.","journal-title":"Br J Dermatol"},{"issue":"1","key":"465_CR83","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/joim.12476","volume":"280","author":"C Slocum","year":"2016","unstructured":"Slocum C, Kramer C, Genco C. Immune dysregulation mediated by the oral microbiome: potential link to chronic inflammation and atherosclerosis. J Intern Med. 2016;280(1):114\u201328.","journal-title":"J Intern Med"},{"issue":"3","key":"465_CR84","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10552-011-9892-7","volume":"23","author":"J Ahn","year":"2012","unstructured":"Ahn J, Chen CY, Hayes RB. Oral microbiome and oral and gastrointestinal cancer risk. Cancer Causes Control. 2012;23(3):399\u2013404.","journal-title":"Cancer Causes Control"},{"issue":"8","key":"465_CR85","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1001\/jamadermatol.2019.0759","volume":"155","author":"MO Machado","year":"2019","unstructured":"Machado MO, Stergiopoulos V, Maes M, et al. Depression and anxiety in adults with hidradenitis suppurativa: a systematic review and meta-analysis. JAMA Dermatol. 2019;155(8):939\u201345.","journal-title":"JAMA Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-020-00465-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13555-020-00465-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-020-00465-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T18:08:31Z","timestamp":1612375711000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13555-020-00465-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,26]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["465"],"URL":"https:\/\/doi.org\/10.1007\/s13555-020-00465-w","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,26]]},"assertion":[{"value":"7 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}